CLINICAL FEATURES AND OUTCOMES OF ISONIAZID MONO-RESISTANT PULMONARY TUBERCULOSIS

被引：0
|
作者：
Chierakul, Nitipatana [1 ]
Saengthongpinij, Vorachai [1 ]
Foongladda, Suporn [1 ]
机构：
[1] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand
来源：
RESPIROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [21] Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru
    Villegas, Leonela
    Otero, Larissa
    Sterling, Timothy R.
    Huaman, Moises A.
    Van der Stuyft, Patrick
    Gotuzzo, Eduardo
    Seas, Carlos
    PLOS ONE, 2016, 11 (04):
  • [22] Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
    Van Deun, Armand
    Decroo, Tom
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2021, 23
  • [23] Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis
    Alemu, Ayinalem
    Bitew, Zebenay Workneh
    Diriba, Getu
    Seid, Getachew
    Moga, Shewki
    Abdella, Saro
    Gashu, Emebet
    Eshetu, Kirubel
    Tollera, Getachew
    Dangisso, Mesay Hailu
    Gumi, Balako
    PLOS ONE, 2023, 18 (07):
  • [24] Rifampicin Mono-Resistant Tuberculosis-A Review of an Uncommon But Growing Challenge for Global Tuberculosis Control
    Malenfant, Jason H.
    Brewer, Timothy F.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (02):
  • [25] Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
    Gopie, F. A.
    Commiesie, E.
    Baldi, S.
    Kamst, M.
    Kaur, D.
    de Lange, W. C. M.
    Pinas, P. S.
    Stijnberg, D.
    Wongsokarijo, M.
    Zijlmans, C. W. R.
    de Zwaan, R.
    van Soolingen, D.
    Vreden, S. G. S.
    de Vries, G.
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2021, 23
  • [26] Rifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis
    Vanina Meyssonnier
    Thuy Van Bui
    Nicolas Veziris
    Vincent Jarlier
    Jérôme Robert
    BMC Infectious Diseases, 14
  • [27] Treatment of isoniazid-resistant pulmonary tuberculosis
    Yee Hyung Kim
    Gee Young Suh
    Man Pyo Chung
    Hojoong Kim
    O Jung Kwon
    Seong Yong Lim
    Si Young Lim
    Won-Jung Koh
    BMC Infectious Diseases, 8
  • [28] Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
    Jhun, Byung Woo
    Koh, Won-Jung
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2020, 83 (01) : 20 - 30
  • [29] Treatment of isoniazid-resistant pulmonary tuberculosis
    Kim, Yee Hyung
    Suh, Gee Young
    Chung, Man Pyo
    Kim, Hojoong
    Kwon, O. Jung
    Lim, Seong Yong
    Lim, Si Young
    Koh, Won-Jung
    BMC INFECTIOUS DISEASES, 2008, 8 (1)
  • [30] Rifampicin mono-resistant tuberculosis in France: a 2005-2010 retrospective cohort analysis
    Meyssonnier, Vanina
    Thuy Van Bui
    Veziris, Nicolas
    Jarlier, Vincent
    Robert, Jerome
    BMC INFECTIOUS DISEASES, 2014, 14
12345